IL33 and breast carcinoma: In addition, we identified five ceRNA pairs (i.e., CDH5 with FAM212B, CDH5 with GYG2 in Module 45, TRIB1 with IL33, TRIB1 with INMT, and TRIB1 with MMRN1 in Module 110) that can be used as prognostic markers of breast cancer in BRCA-associated modules (Figures 6C,D, Supplementary File 9).